Surya Pharma buys ActivOn for $22 m

December 28, 2010 10:43 pm | Updated 10:43 pm IST - NEW DELHI:

The Chandigarh-based Surya Pharmaceuticals on Tuesday announced that it had acquired the U.S.-based over-the-counter analgesic drug manufacturer ActivOn for $22 million (about Rs.99 crore).

“Surya Pharma's wholly owned subsidiary, Surya Pharmaceutical (Singapore) Pte Ltd., has acquired ActivOn, a leading OTC (over-the-counter) analgesic drug brand in the U.S., with global marketing rights,'' the company said in a statement here.

Through this acquisition, Surya Pharma will be able to market its products in the U.S. through ActivOn's established marketing network, which includes leading retailers such as Walmart, Walgreen, CVS, Rite Aid, and the like, the statement said. “This acquisition will be instrumental in establishing our presence in the U.S. markets, which would offer an attractive opportunity to launch our OTC/FMCG products using ActivOn's distribution set-up,'' Surya Pharma CEO, Hariom Bhatia said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.